Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 7, 2006

View Archived Issues

Satavaptan reduces paracenteses in cirrhotic patients with ascites

Double-blind trials detail activity of istradefylline in Parkinson's disease

Vandetanib reduces tumors in murine models of hepatocellular carcinoma

Positive preclinical results for SCY-635, a novel Scynexis anti-HCV candidate

Elan updates quarterly progress

AVIDA registry enrolling patients on Vidaza

Research supports study of molecular iodine in breast cancer

VASTox receives grant in support of spinal muscular atrophy program

IND cleared for study of rhMBL in liver transplant patients

Gladstone Institutes and Merck & Co. form apoE collaboration in neurodegeneration

Introgen gains license supporting combination of Advexin and EGFR inhibitors

AstraZeneca expands development plan for CytoFab

SPA agreement for pivotal study of StemEx

Inyx to manufacture Plethora's topical HFA aerosol for premature ejaculation

KB-2115 begins phase II for dyslipidemia

Pivotal study of MBP-8298 for MS expanded into Baltic countries

VaxGen's second phase II trial of rPA-102 delayed by clinical hold

Enrollment temporarily suspended in lung cancer study of Xyotax

Dutch Government invests in development of TB drugs

New data on effect of ZIO-201 on human pediatric sarcoma models

Microdosing/phase 0 trials: Paradigm shift aims to speed new drug development, improve efficiency

Prexige completes European mutual recognition procedure for osteoarthritis

Approvable letter for Entereg in postoperative ileus

Lorus presents novel pharmacokinetics data on GTI-2040 at the AAPS meeting

KRN-383, a novel Flt3 inhibitor, shows promise in murine models of AML

Positive preclinical data presented for PYM-50028 in Parkinson's disease

Beneficial effects of CB1 antagonism in models of Parkinson's disease

Recent patents report new therapeutic agents for anxiety, depression, sleep disorders, etc.

Recent Novo Nordisk and Roche patents disclose novel treatment strategies for obesity

Novel immunosuppressant agents disclosed by Pharmacopeia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...